News

Phi Optics at 29th New Zealand Conference on Microscopy – AXT Pty Ltd booth #10, November 11-14, 2019

Phi Optics at 29th New Zealand Conference on Microscopy – AXT Pty Ltd booth #10, November 11-14, 2019

AXT Pty Ltd, exclusive distributor of Phi Optics instruments in Australia and New Zealand is presenting Phi Optics SLIM and...

QLI Lab at UIUC reveals epi-GLIM for imaging opaque structures

QLI Lab at UIUC reveals epi-GLIM for imaging opaque structures

Researchers in the QLI Lab at UIUC Beckman Institute, lead by Prof. Gabriel Popescu have developed a new technique for...

Phi Optics @2019 Protein Stability Conference

Phi Optics @2019 Protein Stability Conference

Stop by our live demo to see how Phi Optics SLIM delivers the future in protein aggregates testing and more:...

Phi Optics CEO invited to speak about QPI at MMC2019 in Manchester

Phi Optics CEO invited to speak about QPI at MMC2019 in Manchester

Dr. Gabriel Popescu is an invited speaker at the “Frontiers in BioImaging Sessions” at MMC Frontiers in BioImaging: Label-free Quantitative...

Radiation Oncology testing with SLIM & GLIM at UCCI

Radiation Oncology testing with SLIM & GLIM at UCCI

Phi Optics recently concluded an intense demo of our quantitative phase imaging systems at the University of Cincinnati Cancer Institute...

Phi Optics SLIM and Biofuel Applications

Phi Optics SLIM and Biofuel Applications

Researchers at the University of Idaho PNNLab and MIT used Phi Optics CellVista SLIM Pro system to observe the trade-off...

New Look Website!

New Look Website!

We are excited to announce our new website, https://www.phioptics.com! Check out SLIM and GLIM and the various applications for the...

test

New at Phi Optics booth 1227 @ASCB2018

ASCB-2018-San-Diego

See us at ASCB in San Diego

Phi Optics is the maker of high quality, label-free microscopy systems for live cells and tissues.

PharmSci360

Phi Optics to exhibit the AAPS PHARMSCI360 Conference

Phi Optics, Inc, makers of novel quantitative phase imaging (QPI) systems for bio pharma and academic research,

1 2 3
Contact us